Cipla Limited — Cetirizine Exporter Profile
Indian Pharmaceutical Exporter · #12 for Cetirizine · $4.3M export value · DGFT Verified
Cipla Limited is the #12 Indian exporter of Cetirizine with $4.3M in export value and 373 verified shipments. Cipla Limited holds a 2.4% market share in Cetirizine exports across 15 countries. The company exports 98 pharmaceutical products worth $1.1B across 26 therapeutic categories.
Cipla Limited — Cetirizine Export Profile: Buyers & Destinations
Where Does Cipla Limited Export Cetirizine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $1.3M | 64 | 33.3% |
| SRI LANKA | $1.1M | 93 | 26.5% |
| UNITED KINGDOM | $640.9K | 92 | 15.9% |
| TANZANIA | $295.4K | 28 | 7.3% |
| BELGIUM | $176.9K | 22 | 4.4% |
| OMAN | $147.7K | 9 | 3.7% |
| MADAGASCAR | $122.7K | 25 | 3.0% |
| CZECH REPUBLIC | $66.3K | 12 | 1.6% |
| YEMEN, DEMOCRATIC | $46.6K | 3 | 1.2% |
| YEMEN | $41.0K | 4 | 1.0% |
Cipla Limited exports Cetirizine to 16 countries. The largest destination is SOUTH AFRICA accounting for 33.3% of Cipla Limited's Cetirizine shipments, followed by SRI LANKA (26.5%) and UNITED KINGDOM (15.9%). These destinations reflect Cipla Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cetirizine from Cipla Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BREATHEFREE LANKA PVT LTD | SRI LANKA | $841.3K | 69 |
| MEDPRO PHARMACEUTICA (PTY) LTD | SOUTH AFRICA | $643.4K | 42 |
| ALLOGA UK LTD | UNITED KINGDOM | $640.9K | 92 |
| JD PHARMACY | TANZANIA | $295.4K | 28 |
| BREATHEFREE LANKA PRIVATE LIMITED | SRI LANKA | $227.8K | 24 |
| MEDPRO PHARMACEUTICA PTY LTD | SOUTH AFRICA | $198.3K | 6 |
| MEDPRO PHARMACEUTICA (PTY) LTD. | SOUTH AFRICA | $168.1K | 5 |
| MEDPRO PHARMACEUTICA PTY LTD T A | SOUTH AFRICA | $150.0K | 3 |
| CAPITAL PHARMACY | OMAN | $147.7K | 9 |
| MEDPRO PHARMACEUTICA (PTY) LTD, | SOUTH AFRICA | $146.9K | 4 |
Cipla Limited supplies Cetirizine to 31 buyers globally. The largest buyer is BREATHEFREE LANKA PVT LTD (SRI LANKA), followed by MEDPRO PHARMACEUTICA (PTY) LTD (SOUTH AFRICA) and ALLOGA UK LTD (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cetirizine Export Value and How Much Does Cipla Limited Contribute?
India exported $82.1M worth of Cetirizine through 8,785 shipments from 649 suppliers to 149 countries, serving 1,814 buyers globally. Cipla Limited contributes $4.3M to this total, accounting for 2.4% of India's Cetirizine exports. Cipla Limited ships Cetirizine to 16 countries through 31 buyers.
What Is the Average Shipment Value for Cipla Limited's Cetirizine Exports?
Cipla Limited's average Cetirizine shipment value is $11.7K per consignment, based on 373 shipments totaling $4.3M. The largest destination is SOUTH AFRICA (33.3% of Cipla Limited's Cetirizine exports).
How Does Cipla Limited Compare to Other Indian Cetirizine Exporters?
Cipla Limited ranks #12 among 649 Indian Cetirizine exporters with a 2.4% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($9.8M), MICRO LABS LIMITED ($7.8M), MARKSANS PHARMA LIMITED ($7.7M). Cipla Limited processed 373 shipments to 15 destination countries.
What Cetirizine Formulations Does Cipla Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ALLECET SYRUP (CETIRIZINE HYDROCHLORIDE | $405.2K | 18 |
| ALERID 10MG TAB (CETIRIZINE HYDROCHLORID | $291.2K | 30 |
| ALLECET SYRUP (CETIRIZINE HYDROCHLORIDE LIQUID SYRUP 5MG/5ML) | $283.8K | 11 |
| CETIRIZINE HYDROCHLORIDE 5MG/5ML ORAL SOLUTION | $244.4K | 44 |
| CETIRIZINE HYDROCHLORIDE 5MG 5ML ORAL SOLUTION 1 X 200 ML | $204.3K | 15 |
| ALERID 10 MG TAB (CETIRIZINE HYDROCHLORI | $119.4K | 9 |
| ALERID SYRUP (CETIRIZINE HYDROCLORIDE 5M | $117.7K | 15 |
| ALLECET SYRUP (CETIRIZINE HYDROCHLORIDELIQUID SYRUP 5MG/5ML)NOS | $114.3K | 21 |
| CETIRIZINE HYDROCHLORIDE 5MG/5ML ORAL SOLUTION (1X200 ML) | $104.8K | 12 |
| ALLECET SYRUP CETIRIZINE HYDROCHLORIDE LIQUID SYRUP 5MG 5ML 32 220 Pack Size 1 X 150 ML | $100.0K | 2 |
Cipla Limited exports 89 distinct Cetirizine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ALLECET SYRUP (CETIRIZINE HYDROCHLORIDE with 18 shipments worth $405.2K.
Regulatory Requirements: Exporting Cetirizine to Key Markets
What Cipla Limited must comply with to export Cetirizine to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cipla Limited Compare to Nearest Cetirizine Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | IPCA LABORATORIES LIMITED | $6.7M | 134 | 12 | $50.0K |
| 10 | GRANULES INDIA LIMITED | $5.7M | 116 | 1 | $49.3K |
| 12 | CIPLA LIMITED ★ | $4.3M | 373 | 15 | $11.7K |
| 1 | FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED | $4.0M | 80 | 12 | $50.0K |
| 3 | AJANTA PHARMA LIMITED | $3.3M | 66 | 4 | $50.0K |
Cipla Limited ranks #12 among 649 Indian Cetirizine exporters. Average shipment value of $11.7K compared to the market average of $126.5K. The closest competitors by value are IPCA LABORATORIES LIMITED and GRANULES INDIA LIMITED.
Which Indian Ports Ship Cetirizine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 986 | 11.2% |
| JNPT/ NHAVA SHEVA SEA | 731 | 8.3% |
| JNPT | 616 | 7.0% |
| SAHAR AIR | 542 | 6.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 491 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 408 | 4.6% |
| DELHI AIR | 381 | 4.3% |
| HYDERABAD ICD | 374 | 4.3% |
Geopolitical & Trade Policy Impact on Cipla Limited's Cetirizine Exports
Cipla's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly acute for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management.
In the United States, recent import policies, including the imposition of 100% tariffs on branded or patented pharmaceutical products effective October 2025, have introduced additional hurdles for Indian exporters. While generic drugs, a significant component of Cipla's portfolio, may be less affected, the overall trade environment demands vigilance and adaptability. Conversely, the India-European Union Free Trade Agreement, concluded in January 2026, offers a promising avenue for Cipla. The agreement aims to eliminate tariffs on pharmaceuticals, potentially enhancing Cipla's competitiveness in the European market and offsetting challenges faced in other regions.
Cipla Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Cipla, given the diverse regulatory environments across its export markets. The company has demonstrated a strong commitment to compliance, as evidenced by the U.S. Food and Drug Administration's (FDA) classification of its Bengaluru facility as Voluntary Action Indicated (VAI) in October 2025. This classification is crucial for sustaining and expanding Cipla's presence in the U.S. market. Additionally, the European Union's evolving regulatory framework, including the Falsified Medicines Directive, necessitates continuous adaptation to ensure compliance and maintain market access.
About Cipla Limited
Cipla Limited exports 98 products worth $1.1B. Beyond Cetirizine, top products include Fluticasone, Amlodipine, Salbutamol, Telmisartan, Salmeterol. View the complete Cipla Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cetirizine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cetirizine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cipla Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 373 individual customs records matching Cipla Limited exporting Cetirizine, covering 89 formulations to 16 countries via 31 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 149+ countries, 1,814+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cetirizine Export Data from Cipla Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cipla Limited's Cetirizine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cipla Limited
Full Company Profile →
98 products · $1.1B total trade · 26 categories
Cetirizine Stats
Company Overview
Top Products by Cipla Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cipla Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cetirizine. For current shipment-level data, contact TransData Nexus.